Market Overview:
The global internal analgesic tablet market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, rising geriatric population, and growing demand for pain relief drugs. Based on type, the global internal analgesic tablet market is segmented into central painkiller, narcotic analgesics, antispasmodic painkillers, anxiolytic analgesics and others. Central painkillers are further sub-segmented into non-steroidal anti-inflammatory drugs (NSAIDs) and opioid medications. Narcotic analgesics are further sub-segmented into morphine sulfate tablets and oxycodone hydrochloride tablets. Antispasmodic painkillers are further sub-segmented into dicyclomine hydrochloride tablets and hyoscyamine sulfate tablets. Anxiolytic analgesics are further sub-segmented into alprazolam extended release capsules and lorazepam orally disintegrating tablets (ODTs). Others include pentazocine lactate injection solution USP 50 mg/mL single dose vial kit (NDC 62717‐0362‐01)and tramadol hydrochloride extended release capsules 100 mg/day dosage form (NDC 00591‐4010‐01).
Product Definition:
An internal analgesic tablet is a type of medication that is used to relieve pain. This type of medication is typically taken orally, and it works by blocking the signals that are sent to the brain from the nerves in the area where the pain is occurring. This can help to reduce or eliminate the pain that is being felt. Internal analgesic tablets are often used to treat moderate to severe pain, and they can be helpful for conditions such as arthritis, back pain, and headaches.
Central Painkiller:
Central Painkiller, also known as CPK or 5-ALA is a naturally occurring substance in the body. It is produced by the adrenal glands and kidneys when needed for pain relief. Central Painkillers are used to relieve chronic pain that has no apparent source. They have been found effective in treating headaches, back ache, arthritis and fibromyalgia among other conditions with very few side effects associated with it's usage which makes it an ideal drug for patients who take medication regularly.
Narcotic Analgesics:
Narcotic analgesics are drugs that relieve pain by suppressing the central nervous system. They act on the central nervous system to alleviate pain. The most commonly used narcotics for therapeutic purposes are codeine, morphine, and hydrocodone. However, there is a huge demand for these products in OTC market due to their non-medical use such as in cough syrups and other over-the-counter medications which are sold without prescription as well as under prescription of doctors.
Application Insights:
The others segment held the largest share of over 40.0% in 2017. The application includes chronic pain, acute pain, cancer pain and other pains. Other types of chronic pains include neurogenic, arthritic and rheumatoid arthritis as well as low backache; whereas other types of acute pains include burns and headache. Increasing awareness regarding the availability of alternative treatment options for various diseases is anticipated to drive the demand for internal analgesic tablets over the forecast period.
Hospital was estimated as the second-largest application segment in 2017 owing to increasing utilization rates for various reasons such as emergency situations requiring immediate medical care or surgeries coupled with rising prevalence rate for several diseases such as cancer which also drives demand from this specific application segment over forecast period thereby contributing towards overall market growth during this time frame.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key companies and well-established healthcare infrastructure. The region is expected to maintain its dominance over the forecast period as well due to high disposable income, improved lifestyle, and availability of advanced treatment options.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising demand for pain management in this region due mainly on demographic factors such as aging population and increasing prevalence of chronic diseases coupled with rising awareness about alternative therapies for pain management. In addition, economic development in countries like India & China has led these nations becoming manufacturing hubs for various pharmaceutical products including tablets which will further boost growth during the projected time frame.
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to grow at a CAGR of 5.0% from 2016 to 2020. This will lead to an increase in the demand for internal analgesic tablets, as this population is more susceptible to pain.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, arthritis, and diabetes is increasing globally, which will lead to an increase in the demand for internal analgesic tablets.
- Growing awareness about pain management: There is growing awareness among people about the importance of pain management and its various treatment options. This will lead to an increase in the demand for internal analgesic tablets.
Scope Of The Report
Report Attributes
Report Details
Report Title
Internal Analgesic Tablet Market Research Report
By Type
Central Painkiller, Narcotic Analgesics, Antispasmodic Painkillers, Anxiolytic Analgesics, Others
By Application
Home Use, Hospital, Clinic, Others
By Companies
Advil, Aleve, Tyleol, Bayer, Advei PM, Excedrin Migraine, Motrin IB, Excdrin, BC, Advil
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
163
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Internal Analgesic Tablet Market Report Segments:
The global Internal Analgesic Tablet market is segmented on the basis of:
Types
Central Painkiller, Narcotic Analgesics, Antispasmodic Painkillers, Anxiolytic Analgesics, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Home Use, Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Advil
- Aleve
- Tyleol
- Bayer
- Advei PM
- Excedrin Migraine
- Motrin IB
- Excdrin
- BC
- Advil
Highlights of The Internal Analgesic Tablet Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Central Painkiller
- Narcotic Analgesics
- Antispasmodic Painkillers
- Anxiolytic Analgesics
- Others
- By Application:
- Home Use
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Internal Analgesic Tablet Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An internal analgesic tablet is a medication that is taken by mouth to relieve pain. Internal analgesics work by blocking the sensation of pain signals from the brain.
Some of the key players operating in the internal analgesic tablet market are Advil, Aleve, Tyleol, Bayer, Advei PM, Excedrin Migraine, Motrin IB, Excdrin, BC, Advil.
The internal analgesic tablet market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Internal Analgesic Tablet Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Internal Analgesic Tablet Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Internal Analgesic Tablet Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Internal Analgesic Tablet Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Internal Analgesic Tablet Market Size & Forecast, 2020-2028
4.5.1 Internal Analgesic Tablet Market Size and Y-o-Y Growth
4.5.2 Internal Analgesic Tablet Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Central Painkiller
5.2.2 Narcotic Analgesics
5.2.3 Antispasmodic Painkillers
5.2.4 Anxiolytic Analgesics
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Home Use
6.2.2 Hospital
6.2.3 Clinic
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Internal Analgesic Tablet Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Internal Analgesic Tablet Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Central Painkiller
9.6.2 Narcotic Analgesics
9.6.3 Antispasmodic Painkillers
9.6.4 Anxiolytic Analgesics
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Home Use
9.10.2 Hospital
9.10.3 Clinic
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Central Painkiller
10.6.2 Narcotic Analgesics
10.6.3 Antispasmodic Painkillers
10.6.4 Anxiolytic Analgesics
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Home Use
10.10.2 Hospital
10.10.3 Clinic
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Central Painkiller
11.6.2 Narcotic Analgesics
11.6.3 Antispasmodic Painkillers
11.6.4 Anxiolytic Analgesics
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Home Use
11.10.2 Hospital
11.10.3 Clinic
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Central Painkiller
12.6.2 Narcotic Analgesics
12.6.3 Antispasmodic Painkillers
12.6.4 Anxiolytic Analgesics
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Home Use
12.10.2 Hospital
12.10.3 Clinic
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Central Painkiller
13.6.2 Narcotic Analgesics
13.6.3 Antispasmodic Painkillers
13.6.4 Anxiolytic Analgesics
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Home Use
13.10.2 Hospital
13.10.3 Clinic
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Internal Analgesic Tablet Market: Competitive Dashboard
14.2 Global Internal Analgesic Tablet Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Advil
14.3.2 Aleve
14.3.3 Tyleol
14.3.4 Bayer
14.3.5 Advei PM
14.3.6 Excedrin Migraine
14.3.7 Motrin IB
14.3.8 Excdrin
14.3.9 BC
14.3.10 Advil
